Angiomax (The Medicines Company)


Welcome to the PulseAid listing for the Angiomax drug offered from The Medicines Company. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: The Medicines Company
NON-PROPRIETARY NAME: bivalirudin
SUBSTANCE NAME: BIVALIRUDIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2000-12-15
END MARKETING DATE: 0000-00-00


Angiomax HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAngiomax from The Medicines Company
LABELER NAME: The Medicines Company
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2000-12-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65293-001_2a108b35-deed-460f-9efb-286583b17910
PRODUCT NDC: 65293-001
APPLICATION NUMBER: NDA020873

Other BIVALIRUDIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex corpBivalirudin
Dr. Reddy’s Laboratories LimitedBivalirudin
Fresenius Kabi USA, LLCBivalirudin
Hospira, Inc.Bivalirudin
Sagent Pharmaceuticalsbivalirudin
Sandozbivalirudin
The Medicines CompanyAngiomax